Evaluation of Human Papillomavirus Infections in Prostatic Disease: a Cross-Sectional Study in Iran |
Ghasemian, Ehsan
(Department of Microbiology, Science and Research Branch, Islamic Azad University)
Monavari, Seyed Hamid Reza (Department of Virology, Faculty of Medicine and Antimicrobial Resistance Research Center, Tehran University of Medical Sciences) Irajian, Gholam Reza (Department of Microbiology, School of Medicine, Shahed University) Nodoshan, Mohammad Reza Jalali (Department of Pathology, School of Medicine, Shahed University) Roudsari, Rouhollah Vahabpour (Department of Virology, Faculty of Medicine and Antimicrobial Resistance Research Center, Tehran University of Medical Sciences) Yahyapour, Yousef (Department of Virology, Faculty of Medicine and Antimicrobial Resistance Research Center, Tehran University of Medical Sciences) |
1 | Dodd JG, Paraskevas M, McNicol PJ (1993). Detection of Human papillomavirus 16 transcription in human prostate tissue. J Urol, 149, 400-2. |
2 | Gazzaz FS, Mosli HA (2009). Lack of detection of Human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J, 30, 633-7. |
3 | Goldenberg D, Begum S, Westra WH, et al (2008). Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck, 30, 898-903. DOI ScienceOn |
4 | Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99. DOI ScienceOn |
5 | Hamid AR, Umbas R, Mochtar CA (2011). Recent role of inflammation in prostate diseases: chemoprevention development opportunity. Acta Med Indones, 43, 59-65. |
6 | Hrbacek J, Urban M, Hamsikova E, et al (2011). Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a casecontrol study. BMC Cancer, 11, 53. DOI ScienceOn |
7 | Karin AR, Joseph JC, Lori MI, et al (2003). Serologic evidence of Human papillomavirus 16 and 18 infectiond and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 12, 763-8. |
8 | Korodi Z, Dillner J, Jellum E, et al (2005). Human papillomavirus 16, 18 and 33 infections and risk of prostate cancer: a Nordic nested case control study. Cancer Epidemiol Biomarkers Prev, 14, 2952-5. DOI ScienceOn |
9 | Prakash K, Pirozzi G, Elashoff M, et al (2002). Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays. PNAS, 99, 7598-7603. DOI ScienceOn |
10 | Leiros AJ, Galliano SR, Sember ME, Kahn T, Schwarz E, Eiguchi K (2005). Detection of Human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urology, 5, 15. DOI |
11 | Maghrabi JAA (2007). The role of Human papillomavirus infection in prostate cancer. Saudi Med J, 28, 326-33. |
12 | Marklund L, Hammarstedt L (2011). Impact of HPV in oropharyngeal cancer. J Oncol, 10, 509036 |
13 | Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, et al (2010). Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer, 10, 326. DOI ScienceOn |
14 | McNicol PJ, Dodd JG (1991). High prevalence of Human papillomavirus in prostate tissues. J Urol,145, 850-3. |
15 | Noda T, Sasagawa T, Dong Y, et al (1998). Detection of Human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res, 26, 165-9. DOI |
16 | Schindl M, Bachtiary B, Dreier B, et al (2001). Impact of Human papillomavirus infection on the expression of the KAI1 metastasis suppressor protein in invasive cervical cancer. Cancer Lett, 26, 261-6. |
17 | Silvestre RVD, Leal MF, Demachki S, et al (2009). Low frequency of Human papillomavirus detection in prostate tissue from individuals from Northern Brazil. Mem Inst Oswaldo Cruz, 104, 665-7. DOI ScienceOn |
18 | Smelov V, van Moorselaar J, Startsev V, et al (2011). No high-risk Human papillomavirus infection in prostate cancer tissues. Scand J Infect Dis, 43, 399-400. DOI ScienceOn |
19 | Stamatiou K (2009). Management of benign prostatic hypertrophy related urinary retention current trends and perspectives. Urology J, 6, 237-44. |
20 | Tu H, Jacobs SC, Mergner WJ, Kyprianou N (1994). Rare incidence of Human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology, 44, 726-31. DOI ScienceOn |
21 | Webber R (2006). Benign prostatic hyperplasia. Clinical Evidence, 41, 1-31. |
22 | Yahyapour Y, Shamsi-Shahrabadi M, Mahmoudi M, et al (2012). High-risk and low-risk Human papillomavirus in esophageal squamous cell carcinoma at Mazandaran, Northern Iran. Pathol Oncol Res, [Epub ahead of print]. |
23 | Yahyapour Y, Shamsi-Shahrabadi M, Mahmoudi M, et al (2012). Evaluation of human papilloma virus infection in patients with esophageal squamous cell carcinoma from the Caspian Sea area, north of Iran. Asian Pac J Cancer Prev, 13, 1261-6. DOI ScienceOn |
24 | Chen AC, Waterboer T, Keleher A, et al (2011). Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathol Oncol Res, 17, 613-7. DOI ScienceOn |
25 | Adami HO, Kuper H, Andersson SO, Bergstrom R, Dillner J (2003). Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev, 12, 872-5. |
26 | Aghakhani A, Hamkar R, Parvin M, et al (2011). The role of Human papillomavirus infection in prostate carcinoma. Scand J Infect Dis, 43, 64- 9. DOI ScienceOn |
27 | Anwar K, Nakakuki K, Shiraishi T, et al (1992). Presence of ras oncogene mutations and Human papillomavirus DNA in human prostate carcinomas. Cancer Res, 52, 5991-6. |
28 | Dell G, Gaston K (2001). Contributions in the domain of cancer research: ReviewHuman papillomavirus es and their role in cervical cancer. CMLS, 58, 12-3. |